INTIMAL HYPERPLASIA IS REDUCED BY ORNITHINE DECARBOXYLASE INHIBITION

被引:18
作者
ENDEAN, ED
KISPERT, JF
MARTIN, KW
OCONNOR, W
机构
[1] UNIV KENTUCKY,MED CTR,DEPT PATHOL,LEXINGTON,KY 40536
[2] VET ADM MED CTR,LEXINGTON,KY 40511
关键词
D O I
10.1016/0022-4804(91)90054-P
中图分类号
R61 [外科手术学];
学科分类号
摘要
Polyamines are intracellular cations that are thought to play a role in the regulation of cell growth and differentiation. This study was undertaken to determine if inhibition of ornithine decarboxylase (ODC), the rate-limiting enzyme of polyamine synthesis, suppresses formation of intimal hyperplasia (IH) after arterial injury. Twenty New Zealand white rabbits underwent balloon catheter deendothelialization of a common carotid artery. Treated animals (n = 10) were given α-difluoromethylornithine (DFMO), an inhibitor of ODC, ad lib in drinking water as a 2% solution. DFMO was begun 3 days prior to surgery and continued until vessel harvest. Vessels were perfusion-fixed at harvest, 2 (n = 10) and 4 (n = 10) weeks postoperatively. All arteries remained patent. There were no histologic differences in the IH between treated and untreated animals. The intima and media surface areas on serial arterial cross sections were determined using computer-assisted planimetry. There was a significant difference in the IH surface area of injured arteries between untreated and DFMO-treated animals at both 2 (17.6 ± 2.0 vs 3.0 ± 1.6 μm2; P ≤ 0.001) and 4 weeks (27.4 ± 5.6 vs 7.1 ± 1.8 μm2; P ≤ 0.008). No differences were seen in medial thickness. We conclude that ODC inhibition reduces early development of IH after arterial deendothelialization. These data support the hypothesis that polyamines may be cellular messengers involved in the regulation of IH formation. © 1991.
引用
收藏
页码:634 / 637
页数:4
相关论文
共 22 条
[1]  
CHERVU A, 1990, SURG GYNECOL OBSTET, V171, P433
[2]   EFFICACY OF CORTICOSTEROIDS IN SUPPRESSION OF INTIMAL HYPERPLASIA [J].
CHERVU, A ;
MOORE, WS ;
QUINONESBALDRICH, WJ ;
HENDERSON, T .
JOURNAL OF VASCULAR SURGERY, 1989, 10 (02) :129-134
[3]  
CLOWES AW, 1983, LAB INVEST, V49, P327
[4]   PHARMACOLOGICAL CONSEQUENCES OF INHIBITION OF POLYAMINE BIOSYNTHESIS WITH DL-ALPHA-DIFLUOROMETHYL-ORNITHINE [J].
FOZARD, JR ;
KOCHWESER, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (03) :107-110
[5]   INHIBITION OF MURINE EMBRYONIC-DEVELOPMENT BY ALPHA-DIFLUOROMETHYLORNITHINE, AN IRREVERSIBLE INHIBITOR OF ORNITHINE DECARBOXYLASE [J].
FOZARD, JR ;
PART, ML ;
PRAKASH, NJ ;
GROVE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 65 (04) :379-391
[6]  
FOZARD JR, 1980, SCIENCE, V208, P505
[7]  
GILLESPIE MN, 1985, RES COMMUN CHEM PATH, V50, P365
[8]   ANTI-PLATELET THERAPY REDUCES AORTIC INTIMAL HYPERPLASIA DISTAL TO SMALL DIAMETER VASCULAR PROSTHESES (PTFE) IN NON-HUMAN PRIMATES [J].
HAGEN, PO ;
WANG, ZG ;
MIKAT, EM ;
HACKEL, DB .
ANNALS OF SURGERY, 1982, 195 (03) :328-339
[9]   CHANGES IN L-ORNITHINE DECARBOXYLASE ACTIVITY DURING CELL-CYCLE [J].
HEBY, O ;
GRAY, JW ;
LINDL, PA ;
MARTON, LJ ;
WILSON, CB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 71 (01) :99-105
[10]   HEPARIN REGULATES SMOOTH-MUSCLE S-PHASE ENTRY IN THE INJURED RAT CAROTID-ARTERY [J].
MAJESKY, MW ;
SCHWARTZ, SM ;
CLOWES, MM ;
CLOWES, AW .
CIRCULATION RESEARCH, 1987, 61 (02) :296-300